Author(s)

Nicoletta Masera, Alessandro Cattoni, Valentina Decimi, Valeria D’Apolito, Cristina Arosio, Raffaella Mariani, Alberto Piperno

Consortium for Human Molecular Genetics, Monza, Italy.
Department of Health Sciences, University of Milano-Bicocca, Ospedale S. Gerardo, Monza, Italy.
Department of Pediatrics, University of Milano-Bicocca, Ospedale S. Gerardo, Monza, Italy.

We report the case of a 7 years old girl with Juvenile Hemochromatosis, due to homozygous mutation of HJV, which had increased serum iron indices and liver iron overload in the absence of any clinical sign of disease. Oral iron chelation with low dose deferasirox showed good efficacy and no side effects. The oral iron chelator deferasirox could be a valid option for removing excess iron in early Juvenile Hemochromatosis.

Juvenile Hemochromatosis; Deferasirox; Iron Chelation; Child; Iron Overload

Masera, N. , Cattoni, A. , Decimi, V. , D’Apolito, V. , Arosio, C. , Mariani, R. and Piperno, A. (2013) Efficacy of deferasirox for the treatment of iron overload in a child affected by Juvenile Hemochromatosis. Case Reports in Clinical Medicine, 2, 126-128. doi: 10.4236/crcm.2013.22033.